Virginia Economic Review
Our quarterly publication, Virginia Economic Review, provides an insider look at Virginia’s economy, its diverse array of world-class companies, its amazing talent, and its stunning natural beauty, as well as insights from national thought leaders.
Behind the Rise of a Research Center in Roanoke
Investments from Virginia Tech, Carilion support critical studies in brain, heart, and cancer issues.
Read More
Continuous Improvement
The pharmaceutical manufacturing innovation that came out of a Virginia university is changing the way medicines are made. The Commonwealth’s universities and the rest of its biopharma research community are making sure Virginia is ready to make the medicines of the future.
Read More
Enabling Innovation
Across Virginia, local life sciences ecosystems are helping researchers connect with the funding and facilities they need to grow.
Read More
Behind the Effort to Bring Drug Manufacturing Back to U.S. Shores
Merck, Eli Lilly, Astra Zenec and more have made investments to expand in Virginia, signalling a broader surge in U.S.-based biopharma manufacturing as major drugmakers invest billions to bring production stateside. Driven by pandemic-era supply chain risks and new policy incentives, a nationwide…
Read More
Inside Virginia’s Rise to Biopharma Prominence
A look at the partnerships and targeted investment that created the next U.S. biopharma hotspot — and the work that still needs to be done.
Read More
Dulles Prepares for Pharma Growth Through Brussels Partnership
Recent major biopharmaceutical announcements have sent a clear signal from the industry: Virginia is the future of biopharma manufacturing.
Read MorePodcasts
Disrupting Conventional Historical Wisdom
July 13, 2026
A Conversation With Christy Coleman, Executive Director, Jamestown-Yorktown Foundation
A Biopharma Moment Decades in the Making
April 7, 2026
A Conversation With John Newby, CEO, Virginia Bio
The Urgency of Building Healthier Communities
April 1, 2026
A Conversation With Pam Cheng, Executive Vice President of Global Operations and IT and Chief Sustainability Officer, AstraZeneca